Morehouse School of Medicine is a private co-educational medical school in Atlanta, Georgia. Originally a part of Morehouse College, the school became independent in 1981. The school abbreviates its name with its initials "MSM."

During the past decade, Morehouse School of Medicine conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 4 clinical trials were completed, i.e. on average, 17.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Morehouse School of Medicine" #1 sponsor was "Morehouse School of Medicine" with 9 trials, followed by "Duke University" with 6 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Brigham and Women's Hospital" with 2 trials sponsored and "Emory University" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Morehouse School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 11 trials as a collaborator, "Emory University" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Berman Center for Outcomes and Clinical Research" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Morehouse School of Medicine" are "Heart Failure" (8 trials), "Cancer" (4 trials), "Cardiovascular Diseases" (4 trials), "Heart Diseases" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Morehouse School of Medicine" in a lesser frequency.

Most popular intervention types in "Morehouse School of Medicine" are "Drug" (21 trials), "Behavioral" (12 trials), "Other" (6 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Guselkumab" (3 trials), "100 mg enteric-coated aspirin" (1 trials), "12-week lifestyle modification" (1 trials) and "Active Arm #1, #2, Passive Arm #1, #2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Morehouse School of Medicine" are 38 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Morehouse School of Medicine". 1 are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Morehouse School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Morehouse School of Medicine, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".